Department of Gene and Cell Medicine, Mount Sinai School of Medicine, 1425 Madison Avenue, Room 13-02, New York, NY 10029-6574, USA.
Immunity. 2011 Mar 25;34(3):385-95. doi: 10.1016/j.immuni.2011.02.004. Epub 2011 Mar 3.
Myeloid-derived suppressor cells (MDSCs) bear characteristics of precursors for both M1 and M2 macrophages. The molecular mechanism underlying the differentiation into M1 and M2 macrophages and the relationship of this differentiation to antitumor responses remains largely undefined. Herein, we investigate the potential function of paired immunoglobulin-like receptor B (PIR-B), also known as leukocyte immunoglobulin-like receptor subfamily B member 3 (LILRB3) in MDSC differentiation, and its role in tumor-induced immunity. Our studies indicated that MDSCs genetically ablated for PIR-B (Lilrb3(-/-)) underwent a specific transition to M1-like cells when entering the periphery from bone marrow, resulting in decreased suppressive function, regulatory T cell activation activity, primary tumor growth, and lung metastases. Activation of Toll-like receptor (TLR), signal transducers, and activators of transcription 1 (STAT1), and nuclear factor-kappa B (NF-κB) signaling in Lilrb3(-/-) MDSC promoted the acquisition of M1 phenotype. Inhibition of the PIR-B signaling pathway promoted MDSC differentiation into M1 macrophages.
髓系来源的抑制细胞(MDSCs)具有 M1 和 M2 巨噬细胞前体的特征。MDSC 向 M1 和 M2 巨噬细胞分化的分子机制以及这种分化与抗肿瘤反应的关系在很大程度上尚未确定。在此,我们研究了配对免疫球蛋白样受体 B(PIR-B),也称为白细胞免疫球蛋白样受体亚家族 B 成员 3(LILRB3)在 MDSC 分化中的潜在功能,及其在肿瘤诱导免疫中的作用。我们的研究表明,从骨髓进入外周时,缺乏 PIR-B(Lilrb3(-/-))的 MDSC 发生特定的向 M1 样细胞的转变,导致抑制功能、调节性 T 细胞激活活性、原发性肿瘤生长和肺转移减少。TLR 激活,信号转导和转录激活因子 1(STAT1)和核因子-κB(NF-κB)信号在 Lilrb3(-/-)MDSC 中促进了 M1 表型的获得。抑制 PIR-B 信号通路促进了 MDSC 向 M1 巨噬细胞的分化。